Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
I
Indraprastha Medical Corporation Ltd
Score 68/100• Decent
Indraprastha Medical Corporation Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
Company’s Health82/100
Valuation 20/100 · PB 8.6245
Technical Momentum
1M 17.403% 6M 36.965% 1Y 23.022%
Confidence100%
Low leverage (D/E)No promoter pledge
#61
View details ➜
E
Emcure Pharmaceuticals Ltd
Score 68/100• Decent
Emcure Pharmaceuticals shows potential for growth, but faces several challenges that could impact its performance.
Company’s Health85/100
Valuation 20/100 · PB 5.5727
Technical Avoid
1M -0.675% 6M 43.36% 1Y -7.873%
Confidence100%
Low leverage (D/E)Decent revenue growth
Promoter pledge present
#62
View details ➜
P
PREVEST DENPRO LTD
Score 68/100• Decent
The stock shows potential but faces challenges in growth consistency and valuation metrics.
Company’s Health98/100
Valuation 20/100 · PB 5.9418
Technical Avoid
1M -7.376% 6M -1.396% 1Y -10.137%
Confidence100%
Low leverage (D/E)No promoter pledge
#63
View details ➜
P
Parnax Lab Ltd
Score 68/100• Decent
Parnax Lab Ltd shows potential in a growing sector but faces significant challenges in growth consistency and profitability metrics.
Company’s Health63/100
Valuation 80/100 · PB 1.782
Technical Avoid
1M -5.366% 6M 29.085% 1Y -5.037%
Confidence100%
Reasonable PB valuation
Promoter pledge presentThin margins
#64
View details ➜
O
Omkar Pharmachem Ltd
Score 68/100• Decent
Omkar Pharmachem Ltd shows potential but faces several challenges that may hinder growth.
Company’s Health68/100
Valuation 60/100 · PB 2.9998
Technical Avoid
1M 4.775% 6M -6.5% 1Y 0.972%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#65
View details ➜
M
Medicamen Organics Ltd
Score 68/100• Decent
Medicamen Organics Ltd shows potential for growth but faces several challenges that could impact its performance.
Company’s Health94/100
Valuation 80/100 · PB 1.3051
Technical Avoid
1M 1.143% 6M 29.278% 1Y -37.095%
Confidence100%
Low leverage (D/E)No promoter pledge
#66
View details ➜
M
Medicamen Biotech Ltd
Score 68/100• Decent
Medicamen Biotech Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
Company’s Health62/100
Valuation 60/100 · PB 2.0387
Technical Avoid
1M -11.367% 6M -35.283% 1Y -41.857%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#67
View details ➜
M
Medi-Caps Ltd
Score 68/100• Decent
Medi-Caps Ltd shows potential but faces challenges in growth and profitability metrics. Caution is advised.
Company’s Health51/100
Valuation 100/100 · PB 0.3705
Technical Avoid
1M -7.175% 6M -16.982% 1Y -25.264%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#68
View details ➜
M
Medi Assist Healthcare Services Ltd
Score 68/100• Decent
Medi Assist Healthcare Services Ltd shows potential for growth, but faces challenges in profitability and valuation metrics.
Company’s Health83/100
Valuation 20/100 · PB 7.41
Technical Watch
1M 7.756% 6M 19.695% 1Y -17.428%
Confidence100%
Low leverage (D/E)No promoter pledge
#69
View details ➜
I
Indegene Ltd
Score 68/100• Decent
Indegene Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability consistency and valuation metrics.
Company’s Health80/100
Valuation 20/100 · PB 5.2812
Technical Avoid
1M 0.802% 6M 6.526% 1Y -13.298%
Confidence100%
Low leverage (D/E)No promoter pledge
#70
View details ➜
F
Fredun Pharmaceuticals Ltd
Score 68/100• Decent
Fredun Pharmaceuticals Ltd shows potential for growth but carries risks that need to be monitored closely.
Company’s Health72/100
Valuation 20/100 · PB 5.6771
Technical Momentum
1M 21.352% 6M 115.652% 1Y 88.306%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#71
View details ➜
B
Bajaj Healthcare Ltd
Score 68/100• Decent
Bajaj Healthcare Ltd shows potential in a growing sector, but inconsistencies in growth and profitability metrics warrant caution.
Company’s Health67/100
Valuation 40/100 · PB 3.0936
Technical Avoid
1M 7.944% 6M -26.527% 1Y 19.591%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#72
View details ➜
A
Anuh Pharma Ltd
Score 68/100• Decent
Anuh Pharma Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should proceed with caution.
Company’s Health87/100
Valuation 60/100 · PB 2.5601
Technical Avoid
1M -9.792% 6M -9.556% 1Y -22.66%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#73
View details ➜
K
Kilitch Drugs (India) Ltd
Score 68/100• Decent
Kilitch Drugs shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health87/100
Valuation 40/100 · PB 3.0979
Technical Avoid
1M -0.669% 6M 7.786% 1Y 9.957%
Confidence100%
Low leverage (D/E)No promoter pledge
#74
View details ➜
G
Gujarat Terce Laboratories Ltd
Score 68/100• Decent
Gujarat Terce Laboratories Ltd shows decent potential but faces challenges in profitability and valuation. Investors should proceed with caution.
Company’s Health49/100
Valuation 20/100 · PB 6.1435
Technical Avoid
1M 31.301% 6M -12.75% 1Y -35.463%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#75
View details ➜
Showing 61 to 75 of 301 (21 Pages)